Follow
Essam Metwally
Essam Metwally
Merck
Verified email at metwally.org
Title
Cited by
Cited by
Year
Predicting antibody developability profiles through early stage discovery screening
M Bailly, C Mieczkowski, V Juan, E Metwally, D Tomazela, J Baker, ...
MAbs 12 (1), 1743053, 2020
1462020
Fast rotational matching of rigid bodies by fast Fourier transform acceleration of five degrees of freedom
JA Kovacs, P Chacón, Y Cong, E Metwally, W Wriggers
Acta Crystallographica Section D: Biological Crystallography 59 (8), 1371-1376, 2003
972003
Treating allergic reactions and inflammatory responses with tri-and dipeptides
R Mathison, E Metwally
US Patent 6,586,403, 2003
902003
Submandibular gland tripeptide FEG (Phe-Glu-Gly) and analogues: keys to structure determination
E Metwally, JM Pires, GJ Moore, DA Befus, JS Davison, R Mathison
Peptides 23 (1), 193-199, 2002
182002
Identification of a binding site for the anti-inflammatory tripeptide feG
RD Mathison, JS Davison, E Metwally
Peptides 24 (8), 1221-1230, 2003
132003
A Tree-Based Algorithm for Determining the Effects of Solvation on the Structure of Salivary Gland Tripeptide NH3+-D-PHE-D-GLU-GLY-COO−
E Metwally, HA Ismail, JS Davison, R Mathison
Biophysical journal 85 (3), 1503-1511, 2003
42003
Probing for submandibular gland peptide-T receptors on leukocytes with biotinylated-Lys-[Gly] 6-SGP-T
E Metwally, AD Befus, JS Davison, R Mathison
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1593 (1), 37-44, 2002
42002
Putative interacting binding sites on CD11b and CD16b
R Mathison, JS Davison, E Metwally
PROCEEDINGS-WESTERN PHARMACOLOGY SOCIETY 49, 33, 2006
32006
Tyrosine is detrimental to the biological activity of submandibular gland peptide-T (SGP-T).
E Metwally, JS Davison, RD Mathison
Proceedings of the Western Pharmacology Society 42, 65-66, 1999
31999
Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1α
P Tawa, L Zhang, E Metwally, Y Hou, MA McCoy, WM Seganish, R Zhang, ...
Journal of Biological Chemistry 298 (9), 2022
22022
Optimization and mechanistic investigations of novel allosteric activators of PKG1α
VW Mak, AM Patel, R Yen, J Hanisak, YH Lim, J Bao, R Zheng, ...
Journal of Medicinal Chemistry 65 (15), 10318-10340, 2022
22022
Method for characterizing and analyzing 3-D shapes of molecules utilizing steric multiplets
E Abrahamian, RD Clark, P Fox, E Metwally
US Patent 7,580,799, 2009
12009
Method for characterizing and analyzing 3-D shapes of molecules utilizing steric multiplets
E Abrahamian, RD Clark, P Fox, E Metwally
US Patent 7,212,951, 2007
12007
AbLEF: Antibody Language Ensemble Fusion for thermodynamically empowered property predictions
ZA Rollins, T Widatalla, A Waight, AC Cheng, E Metwally
Bioinformatics, btae268, 2024
2024
Cloud‐Native Rendering Platform and GPUs Aid Drug Discovery
M Ross, M Drummond, L Westerhoff, X Barbeu, E Metwally, ...
Computational Drug Discovery: Methods and Applications 2, 617-626, 2024
2024
Structural insights into selective small molecule activation of PKG1α
E Metwally, V Mak, A Soriano, M Zebisch, HL Silvestre, PA McEwan, ...
Communications Biology 6 (1), 798, 2023
2023
No one-size-fits-all: Evaluation of free energy methods for drug discovery campaigns
K Armacost, XC Yan, Z Guo, E Metwally, H Gunaydin, B Sherborne
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Protein mutagenesis and property optimization with MOE
E Metwally
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Accelerating discovery in the cloud: A cohesive workflow for the virtual screening and refinement of computationally-intensive libraries
E Metwally
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
Organizing 3D project data for structure-based drug design
H Feldman, A Ajamian, E Metwally
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20